Cancer Biotech TetraLogic Pharmaceuticals Files for a $104 Million IPO
TetraLogic Pharmaceuticals, which is developing small molecule therapeutics for the treatment of cancer, filed on Friday with the SEC to raise up to $104 million in an initial public offering. The Malvern, PA-based company, which was founded in 2001, plans to list on the NASDAQ under the symbol TLOG.
Help employers find you! Check out all the jobs and post your resume.